Similar results have been reported by Malvi et al., which demonstrated that the caloric intake restriction and the administration of orlistat, a FASN inhibitor, induces a slowdown of melanoma tumour growth by reducing FASN, pAkt levels, and Cav-1 expression [237]. This evidence concerns the gene FASN and melanoma.